Arcus Biosciences RCUS Cash Flow Statement (2017-2026)

NYSE RCUS
$29.66 -0.47 (-1.56%)
As of: Sep 4, 2026 · 3:58 PM EDT
Reported Financials

Arcus Biosciences Quarterly Cash Flow Statement

Periods 38 quarters
Latest Jun 2026

Arcus Biosciences reported cash from operations of -$119.00M and free cash flow of -$119.00M for the quarter ended Jun 2026, up 10.5% year over year. This cash flow statement covers 38 quarters of results from Mar 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-77.97M279.54M-68.00M-67.00M-65.00M-67.00M-80.00M-75.00M-71.00M-81.00M-4.00M-93.00M-92.00M-94.00M-112.00M-135.00M-106.00M-128.00M-91.00M
Share-based CompensationStock Comp.
14.59M14.29M17.00M15.00M16.26M17.00M19.00M18.00M18.00M18.00M20.00M20.00M19.00M17.00M16.00M15.00M14.00M15.00M19.00M15.00M
Asset Writedowns and ImpairmentWritedown
20.00M
Cash from OperationsCash from Ops.
-53.76M-61.93M654.00M-65.00M-81.00M-70.00M-98.00M-57.00M-63.00M-88.00M-2.00M-94.00M26.00M-100.00M-132.00M-133.00M-97.00M-120.00M-138.00M-119.00M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
-1.39M-2.20M2.00M2.00M2.00M2.00M4.00M4.00M5.00M6.00M6.00M7.00M6.00M6.00M4.00M3.00M3.00M3.00M3.00M2.00M
Depreciation & Amortization (CF)Dep. & Amort.
0.96M1.42M1.00M2.00M2.00M1.00M2.00M2.00M1.00M3.00M3.00M2.00M2.00M3.00M3.00M2.00M2.00M3.00M2.00M3.00M
Change in Working Capital
Change in Account PayablesChange Payables
-1.85M0.42M8.00M4.00M-12.00M8.00M10.00M-19.00M6.00M2.00M-1.00M-1.00M5.00M3.00M8.00M13.00M-3.00M-5.00M
Change in Accured ExpensesChange Accured Exp.
4.92M5.06M-8.46M-1.76M6.09M
Other Working Capital ChangesOther WC Changes
-9.46M-339.62M-18.00M-27.00M-33.00M-34.00M-25.00M6.00M-32.00M-17.00M-42.00M-39.00M67.00M-42.00M-28.00M-160.00M-26.00M-26.00M-17.00M-37.00M
Investing Activities
Capital ExpendituresCapex
7.86M8.43M7.00M-3.00M2.00M8.00M10.00M6.00M-5.00M-10.00M-1.00M-6.00M1.00M-6.00M3.00M
Change in Acquisitions & DivestmentsChange Acquisitions
133.41M117.86M94.00M169.00M228.00M203.00M284.00M258.00M295.00M145.00M222.00M262.00M242.00M203.00M360.00M255.00M243.00M215.00M257.00M225.00M
Cash from Investing ActivitiesCash from Investing
-88.61M18.78M-268.00M-215.00M23.00M47.00M129.00M26.00M11.00M28.00M-169.00M63.00M-29.00M51.00M32.00M137.00M79.00M-182.00M114.00M52.00M
Financing Activities
Other financing activitiesOther financing
1.32M6.56M10.00M4.00M3.00M6.00M1.00M3.00M1.00M3.00M1.00M3.00M2.00M3.00M3.00M7.00M3.00M16.00M
Cash from Financing ActivitiesCash from Financing
1.32M11.33M15.00M4.00M3.00M11.00M1.00M23.00M6.00M3.00M229.00M2.00M48.00M-2.00M142.00M52.00M8.00M286.00M3.00M16.00M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
3.76M2.30M
Net Equity Issued and RepurchasedNet Equity Issued
-0.23M20.00M5.00M228.00M142.00M8.00M279.00M
Additional items
Change in Cash
-141.05M-31.82M401.00M-276.00M-55.00M-12.00M32.00M-8.00M-46.00M-57.00M58.00M-29.00M45.00M-51.00M42.00M56.00M-10.00M-16.00M-21.00M-51.00M
Free Cash FlowFCF
-61.62M-70.36M647.00M-62.00M-83.00M-70.00M-106.00M-57.00M-73.00M-94.00M3.00M-84.00M27.00M-94.00M-133.00M-133.00M-91.00M-120.00M-141.00M-119.00M
Net Cash FlowNCF
-141.05M-31.82M401.00M-276.00M-55.00M-12.00M32.00M-8.00M-46.00M-57.00M58.00M-29.00M45.00M-51.00M42.00M56.00M-10.00M-16.00M-21.00M-51.00M